Synthomer Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Synthomer wird ein jährliches Gewinn- und Umsatzwachstum von 81.3% bzw. 5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 57.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 2.3% betragen.

Wichtige Informationen

81.3%

Wachstumsrate der Gewinne

57.6%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	28.1%
Wachstumsrate der Einnahmen	5.0%
Zukünftige Eigenkapitalrendite	2.3%
Analystenabdeckung	Good
Zuletzt aktualisiert	05 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

May 25

Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 20

Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Mar 14

Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Feb 08

Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

Oct 17

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Sep 12

Synthomer plc's (LON:SYNT) Intrinsic Value Is Potentially 87% Above Its Share Price

Aug 17

Is Synthomer plc (LON:SYNT) Potentially Undervalued?

Jun 21

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

May 27

Is There Now An Opportunity In Synthomer plc (LON:SYNT)?

Dec 19

We Think Synthomer (LON:SYNT) Is Taking Some Risk With Its Debt

Oct 11

At UK£1.66, Is It Time To Put Synthomer plc (LON:SYNT) On Your Watch List?

Sep 20

Gewinn- und Umsatzwachstumsprognosen

LSE:SYNT - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,215	3	35	124	8
12/31/2025	2,093	-24	26	105	8
12/31/2024	1,969	-55	-47	38	8
6/30/2024	1,975	-83	-31	58	N/A
3/31/2024	1,973	-93	18	104	N/A
12/31/2023	1,971	-102	66	150	N/A
9/30/2023	2,047	-125	97	185	N/A
6/30/2023	2,151	-149	129	220	N/A
3/31/2023	2,242	-84	86	177	N/A
12/31/2022	2,332	-18	43	134	N/A
6/30/2022	2,143	80	36	122	N/A
3/31/2022	2,143	139	114	198	N/A
12/31/2021	2,144	198	191	274	N/A
9/30/2021	2,235	213	189	258	N/A
6/30/2021	2,141	217	187	243	N/A
3/31/2021	1,892	110	160	215	N/A
12/31/2020	1,644	3	133	187	N/A
9/30/2020	1,537	14	119	180	N/A
6/30/2020	1,430	24	105	173	N/A
3/31/2020	1,445	54	94	162	N/A
12/31/2019	1,459	85	83	152	N/A
9/30/2019	1,503	81	59	132	N/A
6/30/2019	1,548	77	36	111	N/A
3/31/2019	1,583	89	29	104	N/A
12/31/2018	1,619	100	22	97	N/A
9/30/2018	1,581	101	46	119	N/A
6/30/2018	1,544	102	70	141	N/A
3/31/2018	1,512	88	N/A	137	N/A
12/31/2017	1,480	74	N/A	132	N/A
9/30/2017	1,425	90	N/A	121	N/A
6/30/2017	1,370	105	N/A	111	N/A
3/31/2017	1,208	108	N/A	124	N/A
12/31/2016	1,046	110	N/A	137	N/A
9/30/2016	954	95	N/A	120	N/A
6/30/2016	862	79	N/A	104	N/A
3/31/2016	866	70	N/A	100	N/A
12/31/2015	870	60	N/A	97	N/A
9/30/2015	892	56	N/A	84	N/A
6/30/2015	913	51	N/A	72	N/A
3/31/2015	925	48	N/A	68	N/A
12/31/2014	936	45	N/A	64	N/A
9/30/2014	941	46	N/A	69	N/A
6/30/2014	946	46	N/A	73	N/A
3/31/2014	970	47	N/A	70	N/A
12/31/2013	993	48	N/A	66	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SYNT wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: SYNT wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: SYNT wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: SYNTDie Einnahmen des Unternehmens (5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.5% pro Jahr).

Hohe Wachstumseinnahmen: SYNTDie Einnahmen des Unternehmens (5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SYNTDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (2.3%).

Synthomer Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates upgraded to UK£0.36 loss

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 199%

Consensus EPS estimates upgraded to UK£0.17 loss

Price target increased by 10% to UK£3.03

Consensus EPS estimates fall by 27%

Recent updates

Consensus EPS estimates upgraded to UK£0.36 loss

Consensus EPS estimates fall by 11%

Synthomer plc to Report Fiscal Year 2024 Results on Mar 11, 2025

Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch

High number of new directors

Consensus EPS estimates fall by 199%

First half 2024 earnings released: UK£0.18 loss per share (vs UK£2.08 loss in 1H 2023)

Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)

Synthomer plc Announces Board Changes

Consensus EPS estimates upgraded to UK£0.17 loss

Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?

Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

Price target increased by 10% to UK£3.03

Consensus EPS estimates fall by 27%

Synthomer plc to Report First Half, 2024 Results on Aug 13, 2024

Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

CEO & Executive Director recently bought UK£112k worth of stock

Consensus EPS estimates fall by 82%

Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Full year 2023 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Price target decreased by 16% to UK£6.48

Now 29% overvalued

Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Synthomer plc Provides Earnings Guidance for the Year 2023

Synthomer plc Provides Earnings Guidance for the Year 2023

New minor risk - Insider selling

Consensus EPS estimates upgraded to UK£1.57 loss

Price target decreased by 15% to UK£17.02

Now 24% undervalued after recent price drop

Synthomer plc, Annual General Meeting, May 09, 2024

Price target decreased by 23% to UK£20.14

Consensus EPS estimates upgraded to UK£6.14 loss

Synthomer plc to Report Fiscal Year 2023 Results on Mar 12, 2024

Non-Executive Director recently bought UK£170k worth of stock

Price target increased by 14% to UK£26.20

Price target increased by 16% to UK£26.60

Non-Executive Director recently bought UK£774k worth of stock

Consensus EPS estimates fall by 684%

Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

New major risk - Shareholder dilution

Synthomer plc has completed a Follow-on Equity Offering in the amount of £276.195611 million.

Synthomer plc has completed a Follow-on Equity Offering in the amount of £276.195611 million.

Consensus EPS estimates upgraded to UK£1.88 loss

Synthomer plc(LSE:SYNT) dropped from FTSE 250 Index

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Price target decreased by 8.3% to UK£1.22

First half 2023 earnings released: UK£0.11 loss per share (vs UK£0.18 profit in 1H 2022)

Less than half of directors are independent

Synthomer plc's (LON:SYNT) Intrinsic Value Is Potentially 87% Above Its Share Price

New minor risk - Share price stability

Consensus EPS estimates fall by 136%

Price target decreased by 11% to UK£1.45

Synthomer plc Appoints Martina Flöel as Non-Executive Director

Now 20% undervalued after recent price drop

Is Synthomer plc (LON:SYNT) Potentially Undervalued?

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 31%

Synthomer plc Announces Retirement of Brendan Connolly from the Board

Price target decreased by 12% to UK£1.63

Consensus EPS estimates fall from profit to UK£0.013 loss

Consensus EPS estimates fall from profit to UK£0.013 loss

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Price target decreased by 9.4% to UK£1.94

Synthomer plc to Report Fiscal Year 2022 Results on Mar 28, 2023

Investor sentiment improved over the past week

Is There Now An Opportunity In Synthomer plc (LON:SYNT)?

SURTECO North America, Inc. agreed to acquire Laminates, Films and Coated Fabrics Businesses from Synthomer plc (LSE:SYNT) for approximately $260 million.